Invention Grant
- Patent Title: Multiplexed same type-antigenic peptide
-
Application No.: US15317693Application Date: 2015-06-11
-
Publication No.: US10428112B2Publication Date: 2019-10-01
- Inventor: Kenichi Masuda , Yasuyuki Ishii , Toshihiro Tsukui
- Applicant: RIKEN , ANIMAL ALLERGY CLINICAL LABORATORIES INC. , NIPPON ZENYAKU KOGYO CO., LTD.
- Applicant Address: JP Wako-shi, Saitama JP Sagamihara-shi, Kanagawa JP Koriyama-shi, Fukushima
- Assignee: RIKEN,Animal Allergy Clinical Laboratories Inc.,Nippon Zenyaku Kogyo Co., Ltd.
- Current Assignee: RIKEN,Animal Allergy Clinical Laboratories Inc.,Nippon Zenyaku Kogyo Co., Ltd.
- Current Assignee Address: JP Wako-shi, Saitama JP Sagamihara-shi, Kanagawa JP Koriyama-shi, Fukushima
- Agency: Lucas & Mercanti, LLP
- Priority: JP2014-120999 20140611
- International Application: PCT/JP2015/066865 WO 20150611
- International Announcement: WO2015/190555 WO 20151217
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K7/08 ; A61K39/39 ; C07K16/42 ; C07K17/02 ; A61K39/395 ; C07K16/18

Abstract:
The present invention provides a synthetic peptide capable of inducing an antibody to an autoantigen, and specifically, provides: a multiplexed same type-antigenic peptide having a dendritic core and B-cell recognition peptides, wherein the multiplexed same type-antigenic peptide comprises 4 to 8 B-cell recognition peptides of the same type that are bound to the terminal ends of the dendritic core directly or via a spacer, and each B-cell recognition peptide is bound to the terminal end of the dendritic core directly or via a spacer; an antibody production-inducing agent having the peptides; and a method for producing the peptide.
Public/Granted literature
- US20170158738A1 MULTIPLEXED SAME TYPE-ANTIGENIC PEPTIDE Public/Granted day:2017-06-08
Information query